SCHEMBL131092

SCHEMBL131092

CC(C)C(=O)CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181668 0.81 CYP2D6 (0.36)
SCHEMBL6852628 0.80
SCHEMBL3922771 0.80
Monothioglycerol SCHEMBL3193544 0.79 LMNA (0.48)
Hydrochloric Acid SCHEMBL17275358 0.78 LTA4H (0.38)
Hydrochloric Acid SCHEMBL17275361 0.78 LTA4H (0.38)
SCHEMBL21789070 0.78 MEN1 (0.30)
SCHEMBL2455450 0.78 ECE1 (0.33)
SCHEMBL28708081 0.78 CYP2D6 (0.35)
SCHEMBL28680358 0.78 CYP2D6 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025093527-A1 AN EMULSIFIABLE CONCENTRATE HAVING AN AMIDE/ESTER/CO-SOLVENT SOLVENT SYSTEM BASF SE (DE) 2025-05-08 WO claimed
US-20250109245-A1 PREPARATION OF UNSATURATED POLYESTERS EASTMAN CHEMICAL COMPANY (US) 2025-04-03 US claimed
EP-4473036-A1 PREPARATION OF UNSATURATED POLYESTERS Eastman Chemical Company (US) 2024-12-11 EP claimed
CN-113816867-B Method for preparing atorvastatin calcium intermediate by continuous flow tubular reactor 江苏阿尔法集团盛基药业(宿迁)有限公司 2024-01-12 CN claimed
CN-113788766-B Preparation method of atorvastatin calcium intermediate 江苏阿尔法集团盛基药业(宿迁)有限公司 2024-01-12 CN claimed
WO-2023147330-A1 PREPARATION OF UNSATURATED POLYESTERS EASTMAN CHEMICAL COMPANY (US) 2023-08-03 WO claimed
CN-115466196-A Preparation method of atorvastatin calcium intermediate 宿迁阿尔法科技有限公司 2022-12-13 CN claimed
CN-115260051-A Preparation process of atorvastatin calcium intermediate 江苏阿尔法药业股份有限公司 2022-11-01 CN claimed
EP-3037511-B1 SEMI-AQUEOUS PHOTORESIST OR SEMICONDUCTOR MANUFACTURING RESIDUE STRIPPING AND CLEANING COMPOSITION WITH IMPROVED SILICON PASSIVATION VERSUM MAT US LLC (US) 2022-07-06 EP claimed
CN-113816867-A Method for preparing atorvastatin calcium intermediate by using continuous flow tubular reactor 宿迁盛基医药科技有限公司 2021-12-21 CN claimed
EP-1141059-B1 HIGHLY BRANCHED BLOCK COPOLYMERS CIRCE BIOMEDICAL INC (US) 2003-08-27 EP claimed
JP-2003501431-A 2003-01-14 JP claimed
EP-1141059-A4 HIGHLY BRANCHED BLOCK COPOLYMERS CIRCE BIOMEDICAL INC (US) 2002-03-20 EP claimed
EP-1181291-A2 DNA METHYLTRANSFERASE INHIBITORS THE PENN STATE RESEARCH FOUNDATION (US) 2002-02-27 EP claimed
EP-1141059-A1 HIGHLY BRANCHED BLOCK COPOLYMERS Circe Biomedical, Inc. (US) 2001-10-10 EP claimed
WO-2001018102-A1 NOVEL POLYMER ADDITIVES FOR FORMING OBJECTS KT HOLDINGS, LLC (US) 2001-03-15 WO claimed
US-6172180-B1 POLYETHERS, ACRYLIC POLYMERS, VINYL POLYMERS, ADDITION POLYMERS, POLYAMINES, POLYETHYLENIMINE CIRCE BIOMEDICAL, INC. 2001-01-09 US claimed
WO-2000075142-A2 DNA METHYLTRANSFERASE INHIBITORS THE PENN STATE RESEARCH FOUNDATION (US) 2000-12-14 WO claimed
WO-2000011058-A1 HIGHLY BRANCHED BLOCK COPOLYMERS CIRCE BIOMEDICAL, INC. (US) 2000-03-02 WO claimed
US-5160679-A Urea-formaldehyde adhesive HEXION INC. 1992-11-03 US claimed